missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PTPN14 (aa 725-795) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (82%), Rat (82%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-84173 (PA5-84173. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. The specific function of this PTP has not yet been determined.
Specifications
Specifications
| Accession Number | Q15678 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 5784 |
| Name | Human PTPN14 (aa 725-795) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | C130080N23Rik; cytoskeletal-associated protein tyrosine phosphatase; OTTMUSG00000022087; PEZ; protein tyrosine phosphatase, non-receptor type 14; protein-tyrosine phosphatase pez; Protein-tyrosine phosphatase PTP36; PTP36; PTPD2; Ptpn14; Tyrosine-protein phosphatase non-receptor type 14 |
| Common Name | PTPN14 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction